texas oncology more breakthroughs. more victories
I am a: Patient | Caregiver | Refering Physician

Vipal Pratin Durkal, M.D.

Vipal Pratin Durkal, M.D. Photo

Provider Type: Physician

Specialties:
Board Certifications:
  • Internal Medicine
  • Medical Oncology
Spoken Languages: English, Gujarati, Spanish

Downloads

General Summary

Dr. Durkal has additional experience in clinical research, including novel imaging techniques used in cancer therapy.

To learn more about our Breast Cancer Nurse Navigator program, visit https://www.texasoncology.com/houstonbreastcancer

Education

  • Fellowship in Hematology and Medical Oncology
    University of California Los Angeles Medical Center, Los Angeles, CA
  • Residency in Internal Medicine
    Medical College of Wisconsin, Milwaukee, WI
  • Medical Doctorate
    The University of Texas Health Science Center at Houston, Houston, TX

Awards

  • Texas Top Doctor 2024 Excellence in Medicine

Publications

  • A Novel Artificial Intelligence Biomarker: Validation of the Automated Bone Scan Index (aBSI) in Veterans With Metastatic Prostate Cancer.

    Journal of Clinical Oncology, 2020

  • Exceptions to the Rule: Using Pathology as a Gold Standard To Evaluate the Sensitivity of PSMA PET/CT Modality

    ASCO, 2019

  • Can Response to Treatment Predict Outcome in Patients With Metastatic Pancreatic Adenocarcinoma (MPAC)?

    ASCO, 2016

  • Outcomes in Metastatic Pancreatic adenocarcinoma(MPAC) Patients Treated With FOLFIRINOX (FFX)/FOLFOX(FX) and Gemcitabine + Nab-Paclitaxel (NabG)

    ASCO, 2016

  • Can the Sequence of Chemotherapy Regimens Influence Outcome in Patients With Metastatic Pancreatic Adenocarcinoma (MPAC)?

    ASCO, 2016

Show all Publications
  • Location of Tumor in the Bladder Predicts Likelihood of Lymph Node Metasteses at Radical Cystectomy and Disease Recurrence

    The Journal of Urology, 2011

Latest News

Medical Practice

  • Kelsey-Seybold Clinic, Staff, Hematology-Oncology, Houston, TX (August 2020)

Other Information

Dr. Durkal sits on the Board of Directors for the Texas Society of Clinical Oncology, 2025-2027. Dr. Durkal’s hobbies include running, cooking, community service and spending time with family. He is also interested in readings on health policy and medical history.